Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1936 1
1939 2
1940 1
1941 1
1944 1
1945 2
1946 9
1947 6
1948 8
1949 9
1950 6
1951 17
1952 12
1953 19
1954 18
1955 17
1956 11
1957 11
1958 21
1959 17
1960 15
1961 15
1962 17
1963 21
1964 25
1965 18
1966 10
1967 6
1968 13
1969 7
1970 14
1971 21
1972 13
1973 17
1974 18
1975 46
1976 53
1977 57
1978 68
1979 104
1980 115
1981 165
1982 272
1983 328
1984 431
1985 627
1986 832
1987 880
1988 1003
1989 1385
1990 1416
1991 1517
1992 1625
1993 1723
1994 2131
1995 2172
1996 2536
1997 2755
1998 2893
1999 2942
2000 3398
2001 3495
2002 3781
2003 3853
2004 4540
2005 4878
2006 5346
2007 5490
2008 5870
2009 6353
2010 7296
2011 7779
2012 8715
2013 9321
2014 10193
2015 10745
2016 11277
2017 12064
2018 12691
2019 13526
2020 15595
2021 17403
2022 17811
2023 18493
2024 4214

Text availability

Article attribute

Article type

Publication date

Search Results

227,397 results

Results by year

Filters applied: . Clear all
Page 1
Neuropsychiatric symptoms in Alzheimer's disease.
Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Lyketsos CG, et al. Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410. Alzheimers Dement. 2011. PMID: 21889116 Free PMC article.
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms are currently known to manifest commonly in very early disease and …
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge …
Is Alzheimer's Disease Risk Modifiable?
Serrano-Pozo A, Growdon JH. Serrano-Pozo A, et al. J Alzheimers Dis. 2019;67(3):795-819. doi: 10.3233/JAD181028. J Alzheimers Dis. 2019. PMID: 30776012 Free PMC article. Review.
Population-based clinic-pathological studies have established that the most common pathological substrate of dementia in community-dwelling elderly people is mixed, especially Alzheimer's disease (AD) and cerebrovascular ischemic disease (CVID), rather …
Population-based clinic-pathological studies have established that the most common pathological substrate of dementia in community-dwelling …
Mouse Models of Alzheimer's Disease.
Esquerda-Canals G, Montoliu-Gaya L, Güell-Bosch J, Villegas S. Esquerda-Canals G, et al. J Alzheimers Dis. 2017;57(4):1171-1183. doi: 10.3233/JAD-170045. J Alzheimers Dis. 2017. PMID: 28304309 Review.
Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than 40 million people worldwide and it is predicted to exponentially increase in the coming decades. Because no curative treatment exists, research on the pathophysiology of
Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than 40 million people worldwide an
[Alzheimer's disease - diagnosis and treatment].
Knapskog AB, Engedal K, Selbæk G, Øksengård AR. Knapskog AB, et al. Tidsskr Nor Laegeforen. 2021 Apr 29;141(7). doi: 10.4045/tidsskr.20.0919. Print 2021 May 4. Tidsskr Nor Laegeforen. 2021. PMID: 33950641 Free article. Norwegian.
Alzheimer's disease is the most common cause of dementia globally. Its prevalence will increase considerably in the years to come, in pace with the increasing proportion of older people. No disease-modifying treatment is currently available. Measures t
Alzheimer's disease is the most common cause of dementia globally. Its prevalence will increase considerably in the yea
2016 Alzheimer's disease facts and figures.
Alzheimer's Association. Alzheimer's Association. Alzheimers Dement. 2016 Apr;12(4):459-509. doi: 10.1016/j.jalz.2016.03.001. Alzheimers Dement. 2016. PMID: 27570871
The actual number of deaths to which Alzheimer's disease contributes is likely much larger than the number of deaths from Alzheimer's disease recorded on death certificates. In 2016, an estimated 700,000 Americans age 65 years will die wi …
The actual number of deaths to which Alzheimer's disease contributes is likely much larger than the number of deaths fr …
Biomarkers for preclinical Alzheimer's disease.
Tan CC, Yu JT, Tan L. Tan CC, et al. J Alzheimers Dis. 2014;42(4):1051-69. doi: 10.3233/JAD-140843. J Alzheimers Dis. 2014. PMID: 25024325 Review.
Currently, there is a pressing need to shift the focus to accurate detection of the earliest phase of increasingly preclinical Alzheimer's disease (AD). Meanwhile, the growing recognition that the pathophysiological process of AD begins many years prior to cl …
Currently, there is a pressing need to shift the focus to accurate detection of the earliest phase of increasingly preclinical Alzheimer
Neuroinflammation in Alzheimer's disease: Current evidence and future directions.
Calsolaro V, Edison P. Calsolaro V, et al. Alzheimers Dement. 2016 Jun;12(6):719-32. doi: 10.1016/j.jalz.2016.02.010. Epub 2016 May 11. Alzheimers Dement. 2016. PMID: 27179961 Review.
Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing results. ...In this review, we focus on the potential mechanism of glial activation and how local and systemic factors influence disease
Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing resu …
Female Sex and Alzheimer's Risk: The Menopause Connection.
Scheyer O, Rahman A, Hristov H, Berkowitz C, Isaacson RS, Diaz Brinton R, Mosconi L. Scheyer O, et al. J Prev Alzheimers Dis. 2018;5(4):225-230. doi: 10.14283/jpad.2018.34. J Prev Alzheimers Dis. 2018. PMID: 30298180 Free PMC article. Review.
Along with advanced age and apolipoprotein E (APOE)-4 genotype, female sex is a major risk factor for developing late-onset Alzheimer's disease (AD). Considering that AD pathology begins decades prior to clinical symptoms, the higher risk in women cannot simp …
Along with advanced age and apolipoprotein E (APOE)-4 genotype, female sex is a major risk factor for developing late-onset Alzheimer
Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.
Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS. Hane FT, et al. J Alzheimers Dis. 2017;57(3):645-665. doi: 10.3233/JAD-160907. J Alzheimers Dis. 2017. PMID: 28269772 Free PMC article. Review.
The field of Alzheimer's disease (AD) research has grown exponentially over the past few decades, especially since the isolation and identification of amyloid-beta from postmortem examination of the brains of AD patients. Recently, the Journal of Alzheimer
The field of Alzheimer's disease (AD) research has grown exponentially over the past few decades, especially since the …
Understanding the impact of sex and gender in Alzheimer's disease: A call to action.
Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, Mallampalli MP, Mormino EC, Scott L, Yu WH, Maki PM, Mielke MM. Nebel RA, et al. Alzheimers Dement. 2018 Sep;14(9):1171-1183. doi: 10.1016/j.jalz.2018.04.008. Epub 2018 Jun 12. Alzheimers Dement. 2018. PMID: 29907423 Free PMC article. Review.
INTRODUCTION: Precision medicine methodologies and approaches have advanced our understanding of the clinical presentation, development, progression, and management of Alzheimer's disease (AD) dementia. However, sex and gender have not yet been adequately int …
INTRODUCTION: Precision medicine methodologies and approaches have advanced our understanding of the clinical presentation, development, pro …
227,397 results
You have reached the last available page of results. Please see the User Guide for more information.